Kidswell Bio: Change Report
Kidswell Bio: Announcement of the expiration of the exercise period for the 10th subscription rights (with exercise price adjustment clause).
Kidswell Bio: Change report.
Kidswell Bio: Announcements of individual stocks regarding the monthly exercise status of the fourth unsecured convertible bonds with subscription rights and the 10th, 15th, and 18th subscription rights issued through third-party allocation of shares.
Kidswell Bio: Report on Corporate Governance, June 28th, 2024.
Kidswell Bio: Matters related to business plans and growth potential.
Kidswell Bio: Regarding matters related to dominant shareholders.
Kidswell Bio: Interim report
Kidswell Bio: Confirmatory letter.
Kidswell Bio: Internal Control Report - 24th Period (April 1, 2023 - March 31, 2024)
Kidswell Bio: Financial Report - The 24th Term (2023/04/01 - 2024/03/31)
Kidswell Bio: Partial correction of Notice of the 24th Regular Shareholders' Meeting Convocation
Kidswell Bio: Announcements of individual stocks regarding the conclusion of a business partnership agreement for joint development of new biosimilars with Kaiom Bioscience Co., Ltd.
Kidswell Bio: Announcements of individual stocks regarding the conclusion of a business consignment contract to strengthen collaboration with the Biologics Research and Training Center (BCRET).
Kidswell Bio: Confirmation letter
Kidswell Bio: Corrected Securities Report - 23rd period (April 1, 2022 - March 31, 2023)
Kidswell Bio: Independent Company Executives Declaration
Kidswell Bio: Notice of Convening Regular Shareholders' Meeting for the Year 2024.
Kidswell Bio: Notice Concerning the Monthly Exercise Status of the 4th Unsecured Convertible Bonds with Stock Acquisition Rights and the 10th, 15th, and 18th Stock Acquisition Rights
KIDSWELL BIO: Notice regarding publication of consolidated earnings forecasts due to the transition to consolidated financial results
No Data